Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T09544 Target Info
Target Name Galectin-1 (LGALS1)
Synonyms SLac lectin 1; S-Lac lectin 1; Putative MAPKactivating protein PM12; Putative MAPK-activating protein PM12; Lectin galactosidebinding soluble 1; Lectin galactoside-binding soluble 1; Lactosebinding lectin 1; Lactose-binding lectin 1; HPL; HLBP14; HBL; Galaptin; Gal1; Gal-1; Betagalactosidebinding lectin L14I; Beta-galactoside-binding lectin L-14-I; 14 kDa lectin; 14 kDa lamininbinding protein; 14 kDa laminin-binding protein
Target Type Patented-recorded Target
Gene Name LGALS1
UniProt ID
LEG1_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US8703720
Title Galactoside inhibitors of galectins
Abstract Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, where in the galectin is preferably a galectin-3. The novel compounds are defined by the general formula:
Applicant(s) Galecto Biotech AB
Representative Drug(s) D0N0DD Drug Info N.A. Click to Show More [1]
2 D0N5RH Drug Info N.A. [1]
3 D0D1JC Drug Info N.A. [1]
Patent ID US8703720
Title Galactoside inhibitors of galectins
Abstract Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, where in the galectin is preferably a galectin-3. The novel compounds are defined by the general formula:
Applicant(s) Galecto Biotech AB
Representative Drug(s) D0N0DD Drug Info N.A. Click to Show More [1]
2 D0N5RH Drug Info N.A. [1]
3 D0D1JC Drug Info N.A. [1]
Patent ID US8703720
Title Galactoside inhibitors of galectins
Abstract Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, where in the galectin is preferably a galectin-3. The novel compounds are defined by the general formula:
Applicant(s) Galecto Biotech AB
Representative Drug(s) D0N0DD Drug Info N.A. Click to Show More [1]
2 D0N5RH Drug Info N.A. [1]
3 D0D1JC Drug Info N.A. [1]
References  Top
REF 1 Galactoside inhibitors of galectins. US8703720.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.